251 related articles for article (PubMed ID: 26074449)
1. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
Davalieva K; Kostovska IM; Kiprijanovska S; Markoska K; Kubelka-Sabit K; Filipovski V; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M
Prostate; 2015 Oct; 75(14):1586-600. PubMed ID: 26074449
[TBL] [Abstract][Full Text] [Related]
2. Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.
Ummanni R; Mundt F; Pospisil H; Venz S; Scharf C; Barett C; Fälth M; Köllermann J; Walther R; Schlomm T; Sauter G; Bokemeyer C; Sültmann H; Schuppert A; Brümmendorf TH; Balabanov S
PLoS One; 2011 Feb; 6(2):e16833. PubMed ID: 21347291
[TBL] [Abstract][Full Text] [Related]
3. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
4. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis.
Lin JF; Xu J; Tian HY; Gao X; Chen QX; Gu Q; Xu GJ; Song JD; Zhao FK
Int J Cancer; 2007 Dec; 121(12):2596-605. PubMed ID: 17722004
[TBL] [Abstract][Full Text] [Related]
6. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of infiltrating ductal carcinoma tissues by coupled 2-D DIGE/MS/MS analysis.
Davalieva K; Kiprijanovska S; Broussard C; Petrusevska G; Efremov GD
Mol Biol (Mosk); 2012; 46(3):469-80. PubMed ID: 22888636
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis.
Han ZD; Zhang YQ; He HC; Dai QS; Qin GQ; Chen JH; Cai C; Fu X; Bi XC; Zhu JG; Liao DJ; Lu XP; Mo ZY; Zhu YP; Zhong WD
Med Oncol; 2012 Dec; 29(4):2877-88. PubMed ID: 22215415
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells.
Bindukumar B; Schwartz S; Aalinkeel R; Mahajan S; Lieberman A; Chadha K
Prostate; 2008 Oct; 68(14):1531-45. PubMed ID: 18646040
[TBL] [Abstract][Full Text] [Related]
10. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
[TBL] [Abstract][Full Text] [Related]
11. Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma.
Alaiya AA; Al-Mohanna M; Aslam M; Shinwari Z; Al-Mansouri L; Al-Rodayan M; Al-Eid M; Ahmad I; Hanash K; Tulbah A; Bin Mahfooz A; Adra C
Int J Oncol; 2011 Apr; 38(4):1047-57. PubMed ID: 21305254
[TBL] [Abstract][Full Text] [Related]
12. The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.
Luna-Coronell JA; Vierlinger K; Gamperl M; Hofbauer J; Berger I; Weinhäusel A
Proteomics; 2016 Apr; 16(8):1204-14. PubMed ID: 27089054
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic study of human prostate cancer cells with different metastatic potentials.
Li Q; Li Y; Wang Y; Cui Z; Gong L; Qu Z; Zhong Y; Zhou J; Zhou Y; Gao Y; Li Y
Int J Oncol; 2016 Apr; 48(4):1437-46. PubMed ID: 26846621
[TBL] [Abstract][Full Text] [Related]
14. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.
Guidi F; Puglia M; Gabbiani C; Landini I; Gamberi T; Fregona D; Cinellu MA; Nobili S; Mini E; Bini L; Modesti PA; Modesti A; Messori L
Mol Biosyst; 2012 Apr; 8(4):985-93. PubMed ID: 22134777
[TBL] [Abstract][Full Text] [Related]
15. The effect of pre-existing maternal obesity on the placental proteome: two-dimensional difference gel electrophoresis coupled with mass spectrometry.
Oliva K; Barker G; Riley C; Bailey MJ; Permezel M; Rice GE; Lappas M
J Mol Endocrinol; 2012 Apr; 48(2):139-49. PubMed ID: 22301947
[TBL] [Abstract][Full Text] [Related]
16. 2D gel electrophoresis and mass spectrometry identification and analysis of proteins.
Meleady P
Methods Mol Biol; 2011; 784():123-37. PubMed ID: 21898217
[TBL] [Abstract][Full Text] [Related]
17. Differential profiling of prostate tumors versus benign prostatic tissues by using a 2DE-MALDI-TOF-based proteomic approach.
Kmeťová Sivoňová M; Tatarková Z; Jurečeková J; Kliment J; Híveš M; Lichardusová L; Kaplán P
Neoplasma; 2021 Jan; 68(1):154-164. PubMed ID: 32977723
[TBL] [Abstract][Full Text] [Related]
18. Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer.
Fan Y; Murphy TB; Byrne JC; Brennan L; Fitzpatrick JM; Watson RW
J Proteome Res; 2011 Mar; 10(3):1361-73. PubMed ID: 21166384
[TBL] [Abstract][Full Text] [Related]
19. Cancer biomarker development and two-dimensional difference gel electrophoresis (2D-DIGE).
Kondo T
Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):2-8. PubMed ID: 30392560
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
